Burning Rock Biotech Ltd banner

Burning Rock Biotech Ltd
NASDAQ:BNR

Watchlist Manager
Burning Rock Biotech Ltd Logo
Burning Rock Biotech Ltd
NASDAQ:BNR
Watchlist
Price: 25.16 USD -2.59% Market Closed
Market Cap: $270.7m

Wall Street
Price Targets

BNR Price Targets Summary
Burning Rock Biotech Ltd

There are no price targets for BNR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Burning Rock Biotech Ltd Competitors:
Price Targets
AKTIA
Aktia Bank Abp
0% Upside
NYXH
Nyxoah SA
168% Upside
BTBT
Bit Digital Inc
214% Upside
VINP
Vinci Partners Investments Ltd
19% Upside
OFIX
Orthofix Medical Inc
36% Upside

Revenue
Forecast

16% / Year
Past Growth
49% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
16% / Year
Past Growth
49% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 6 years the compound annual growth rate for Burning Rock Biotech Ltd's revenue is 16%. The projected CAGR for the next 2 years is 49%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
55%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
55%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
43%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
43%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BNR's stock price target?
Not Available

BNR doesn't have any price targets made by Wall Street professionals.

What is Burning Rock Biotech Ltd's Revenue forecast?
Projected CAGR
49%

For the last 6 years the compound annual growth rate for Burning Rock Biotech Ltd's revenue is 16%. The projected CAGR for the next 2 years is 49%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett